LABORATORY CORPORATION OF AMERICA HOLDINGS Funds and ETFs Laboratory Corporation of America Holdings
Equities
LH
US50540R4092
Healthcare Facilities & Services
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 198.4 USD | +0.03% |
|
-1.53% | -12.71% |
| 04-26 | Baird Adjusts Laboratory Corp of America Holdings' Price Target to $244 From $255 | MT |
| 04-26 | Barclays Adjusts Price Target on Laboratory Corp of America Holdings to $213 From $234 | MT |
ETFs positioned on Laboratory Corporation of America Holdings
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 1.97% | 2 M€ | +6.77% | ||
| 1.95% | 8 M€ | +2.44% | ||
| 0.82% | 18 M€ | +3.79% | - | |
| 0.43% | 10 M€ | +5.96% | ||
| 0.39% | 92 M€ | +0.06% | - | |
| 0.27% | 9 M€ | -.--% | - | |
| 0.23% | 1 M€ | +11.94% | - | |
| 0.23% | 13 M€ | -.--% | - | |
| 0.23% | 3 M€ | +7.32% | - | |
| 0.19% | 5 M€ | -72.95% | - | |
| 0.19% | 52 M€ | +6.98% | ||
| 0.18% | 2 M€ | +20.44% | - | |
| 0.15% | 8 M€ | +3.41% | - | |
| 0.15% | 33 M€ | +0.25% | - | |
| 0.15% | 18 M€ | +3.41% | - | |
| 0.14% | 469 M€ | -2.05% | - | |
| 0.14% | 3,859 M€ | +18.82% | - | |
| 0.12% | 2,510 M€ | +12.00% | ||
| 0.11% | 4,592 M€ | +11.18% | ||
| 0.11% | 1,006 M€ | -.--% | - | |
| 0.11% | 414 M€ | +10.21% | - | |
| 0.11% | 322 M€ | +13.88% | - | |
| 0.11% | 29 M€ | -.--% | - | |
| 0.10% | 219 M€ | +17.17% | - | |
| 0.10% | 1,448 M€ | -.--% | - | |
| 0.10% | 9 M€ | +2.75% | - | |
| 0.10% | 736 M€ | +6.09% | ||
| 0.09% | 330 M€ | -.--% | - |
Laboratory Corporation of America Holdings is the No. 2 clinical laboratory in the United States. Net sales (including intragroup) break down by activity as follows:
- clinical laboratory services (63.9%): routine testing, patient diagnosis, disease monitoring and treatment, and other services;
- development and clinical trial services (36.1%): for pharmaceutical, biotechnology, medical device and diagnostic companies.
Net sales are distributed geographically as follows : North America (81.2%), Europe (12.7%) and other (6.1%).
Calendar
2024-05-14
- Annual General Meeting
Related indices
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
198.4
USD
Average target price
239.1
USD
Spread / Average Target
+20.50%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| -12.71% | 16.73B | |
| -14.92% | 84.68B | |
| +13.30% | 81.12B | |
| +10.92% | 29.4B | |
| -3.06% | 16.36B | |
| -2.63% | 14.92B | |
| -31.75% | 11.77B | |
| -1.42% | 11.72B | |
| +27.44% | 11.71B | |
| -3.97% | 11.66B |
- Stock Market
- Equities
- LH Stock
- Funds and ETFs Laboratory Corporation of America Holdings
